Biotechnologies International

Biotechnologies International, Ltd., a new corporation that owns the rights to over 1600 new pharmaceutical products, came to Imaginaria when it was ready to announce itself to the world. It was clear early on that when dealing with such a substantial corporation that seems to appear to the public out of nowhere, the main problem is credibility. Imaginaria developed a consistent image throughout, from logotype, stationary, and marketing material designs as well as product and product packaging designs that clearly communicate the company's message to the market.